School of Medicine
Showing 751-800 of 804 Results
-
Ashira Weinreich
Masters Student in Community Health and Prevention Research, admitted Autumn 2025
BioAshira is a National Science Foundation Graduate Research Fellow (NSF-GRFP), completing her MS in Community Health and Prevention Research at Stanford University (2025 - June 2026), and a Community Engaged Scholar at Stanford's Haas Center for Public Service. Her research examines how diverse bio-cultural systems inform community health in times of sociocultural and ecological change. By linking cyclical patterns in health practices with seasonality, nutrient intake, and medicinal plant use, Ashira explores how village communities adapt to climatic and environmental variability. As a Fulbright Research Fellow in Nepal (2024-2025), Ashira interviewed community members, organized and facilitated workshops in 12 villages ranging in elevation from 6,500ft to 13,000ft, engaging over 200 villagers. She believes that anticipatory capacity is important in developing resilience in Nepal’s high-altitude Himalayan regions. Ashira is committed to a collaborative, community-centered approach to research, emphasizing the importance of reciprocity and giving back to the community.
-
Evelyn Wong
MD Student, expected graduation Spring 2028
Ph.D. Student in Bioengineering, admitted Spring 2026
MSTP StudentCurrent Research and Scholarly InterestsSoft bioelectronics for multi-modal sensing and neural stimulation
-
Xiaojing Xing
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioXiaojing Xing is a health tech founder and product leader working at the intersection of medicine, business, and technology. She has driven AI-powered innovations across hardware and software—building from MVP to scale at both startups and global tech companies.
At Tencent, she led digital health platforms serving over 30 million users and launched AI tools that empowered 200,000+ physicians. Later, as Chief Product Officer at MindLax, she brought a neurofeedback sleep device from concept to market, growing it to thousands of users through data-driven iteration and user empathy.
Recognized on Forbes 30 Under 30 China, Xiaojing blends product management, global go-to-market strategy, and health innovation expertise. She is currently focused on applying AI to consumer health—creating intelligent, accessible technologies that make wellbeing part of everyday life.
Xiaojing holds degrees from Stanford University School of Medicine, Harvard T.H. Chan School of Public Health, and Peking University Health Science Center. -
Christine Yiwen Yeh
MD Student, expected graduation Spring 2027
Ph.D. Student in Biomedical Data Science, admitted Autumn 2020
MSTP StudentBioChristine Yeh is an aspiring physician-scientist with academic training and industry experience in translational bioinformatics and data science. Christine is currently a sixth year MD/PhD candidate in the Medical Scientist Training Program (MSTP) at Stanford. She is interested in advancing cancer care through the integration of clinical oncology, computational cancer biology, and translational research, with the goal of developing more precise and effective therapies. In June 2025, she completed her PhD in Biomedical Data Science. In her doctoral work she developed a novel unsupervised machine learning pipeline grounded in principles of algorithmic fairness and applied it to single-cell spatial transcriptomics and CRISPR-based functional genomics to identify mechanisms of immune evasion and therapeutic vulnerabilities in tubo-ovarian cancer. Prior to MD/PhD training, Christine was a computational structural biologist and drug discovery scientist at D. E. Shaw Research in New York City. There, she built machine learning algorithms for investigating protein structural dynamics and worked on several early drug discovery programs for diabetes and immuno-oncology indications. Christine’s drug target panel included non-receptor protein tyrosine phosphatases encoded by PTPN1 and PTPN11. Her work led to peer-reviewed publications describing lead compounds and a novel small molecule therapeutic that advanced to and completed early phase clinical trials.
-
Harrison G. Zhang
MD Student, expected graduation Spring 2028
Ph.D. Student in Biomedical Data Science, admitted Autumn 2025
MSTP Student
Grad Student, Institute for Human-Centered Artificial Intelligence (HAI)BioHarrison is an artificial intelligence researcher, Stanford MD-PhD trainee in the Medical Scientist Training Program, and Columbia alumnus advancing precision medicine and drug discovery. He studied statistics and biology at Columbia, where he was elected to Phi Beta Kappa and awarded Magna Cum Laude with Highest Honors in Field for his academic achievements.
